{"database": "lobbying", "table": "lobbying_activities", "rows": [[3488765, "401ee552-0bb5-44b4-8573-5a32ee7fc7a0", "Q4", "MEHLMAN CONSULTING, INC.", 284950, "THE CAMPAIGN FOR SUSTAINABLE RX PRICING", 2025, "fourth_quarter", "PHA", "Prescription drug pricing issues. H.R. 1843/S. 1032 - Increasing Transparency in Generic Drug Applications Act. S. 1954 - Biosimilar Red Tape Elimination Act; S. 1095 - Stop Stalling Act S. 1067 - Ensuring Timely Access to Generics Act; S. 2630 - REMEDY Act; H.R.1262 - Mikaela Naylon Give Kids a Chance Act.", "HOUSE OF REPRESENTATIVES,SENATE", 90000, null, 0, 0, "2026-01-16T12:09:15-05:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["3488765"], "units": {}, "query_ms": 11.129254999104887, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}